Opus KSD discloses $680,801 equity sale to 16 investors in Form D filing
The Pembroke, Massachusetts biotechnology firm reported a completed Regulation D offering with a first sale date of September 23, 2026.
SEC filing
Latest
1 story
Sign inSign in1 story
The Pembroke, Massachusetts biotechnology firm reported a completed Regulation D offering with a first sale date of September 23, 2026.
SEC filing